Literature DB >> 6309995

The changing etiology of epidemic keratoconjunctivitis: antigenic and restriction enzyme analyses of adenovirus types 19 and 37 isolated over a 10-year period.

M C Kemp, J C Hierholzer, C P Cabradilla, J F Obijeski.   

Abstract

Strains of adenovirus types 19 (Ad-19) and 37 (Ad-37) isolated from cases of epidemic keratoconjunctivitis (EKC) over a 10-year period were analyzed for differences in antigenic and restriction enzyme patterns. By restriction analysis, 35% of the isolates recovered between 1973 and 1981 and typed by hemagglutination-inhibition tests as Ad-19 were in fact Ad-37. This finding was confirmed by comprehensive serologic tests when Ad-37 reagents became available in 1981. All Ad-19 strains isolated between 1973 and 1980 were identical to the previously described genotype Ad-19A, and these Ad-19A strains exhibited a differential hemagglutination profile distinct from that of Ad-19 and Ad-37 prototypes. The earliest Ad-37 case found in the United States occurred in April 1976; Ad-37 then became the major agent of EKC from 1977 to 1983. Intermediate strains between types 19A and 37 were not detected by either antigenic or restriction fragment analyses. Thus, some genetic event appears to generate new genotypes such as Ad-19A and serotypes such as Ad-37.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309995     DOI: 10.1093/infdis/148.1.24

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  30 in total

1.  Serological and genetic characterisation of a unique strain of adenovirus involved in an outbreak of epidemic keratoconjunctivitis.

Authors:  A K Adhikary; T Inada; U Banik; A Mukouyama; Y Ikeda; M Noda; T Ogino; E Suzuki; T Kaburaki; J Numaga; N Okabe
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

2.  Adenovirus type 37 uses sialic acid as a cellular receptor.

Authors:  N Arnberg; K Edlund; A H Kidd; G Wadell
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Human adenovirus type 9-induced rat mammary tumors.

Authors:  R Javier; K Raska; G J Macdonald; T Shenk
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

4.  Characterization of E3/49K, a novel, highly glycosylated E3 protein of the epidemic keratoconjunctivitis-causing adenovirus type 19a.

Authors:  Mark Windheim; Hans-Gerhard Burgert
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 5.  The sweet spot: defining virus-sialic acid interactions.

Authors:  Jennifer E Stencel-Baerenwald; Kerstin Reiss; Dirk M Reiter; Thilo Stehle; Terence S Dermody
Journal:  Nat Rev Microbiol       Date:  2014-09-29       Impact factor: 60.633

6.  Examination of uncommon clinical isolates of human adenoviruses by restriction endonuclease analysis.

Authors:  G W Hammond; G Mauthe; J Joshua; C K Hannan
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

7.  Comparison of neutralization and DNA restriction enzyme methods for typing clinical isolates of human adenovirus.

Authors:  K H Fife; R Ashley; A F Shields; D Salter; J D Meyers; L Corey
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

8.  Genome variation of 5 clinical adenovirus type 2 isolates determined by restriction enzyme digestion analysis. Brief report.

Authors:  E S McFarlane; J H Stewart; H James
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

9.  DNA restriction analysis of adenovirus prototypes 1 to 41.

Authors:  T Adrian; G Wadell; J C Hierholzer; R Wigand
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

10.  Intermediate human adenovirus type 22/H10,19,37 as a new etiological agent of conjunctivitis.

Authors:  M Noda; Y Miyamoto; Y Ikeda; T Matsuishi; T Ogino
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.